Meritage Portfolio Management Novo Nordisk A S Transaction History

Meritage Portfolio Management

$1.47 Billion
Q1 2025

A detailed history of Meritage Portfolio Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Meritage Portfolio Management holds 193,692 shares of NVO stock, worth $13.1 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

193,692

Previous 199,087 2.71%

Holding current value

$13.1 Million

Previous $17.1 Million 21.47%

% of portfolio

0.91%

Previous 1.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$69.3 - $90.95 $373,873 - $490,675	-5,395 Reduced 2.71%	193,692 $13.4 Million
Q4 2024 Jan 27, 2025	SELL	$85.0 - $120.04 $400,010 - $564,908	-4,706 Reduced 2.31%	199,087 $17.1 Million
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $265,526 - $324,286	-2,230 Reduced 1.08%	203,793 $24.3 Million
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $4.07 Million - $4.87 Million	-33,177 Reduced 13.87%	206,023 $29.4 Million
Q1 2024 Apr 29, 2024	SELL	$102.11 - $135.92 $1.01 Million - $1.34 Million	-9,859 Reduced 3.96%	239,200 $30.7 Million
Q4 2023 Feb 02, 2024	BUY	$87.78 - $105.45 $1.42 Million - $1.7 Million	16,159 Added 6.94%	249,059 $25.8 Million
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $10.6 Million - $23.3 Million	116,578 Added 100.22%	232,900 $21.2 Million
Q2 2023 Jul 31, 2023	BUY	$155.98 - $172.65 $10.2 Million - $11.3 Million	65,508 Added 128.92%	116,322 $18.8 Million
Q1 2023 Apr 25, 2023	BUY	$132.34 - $159.14 $6.72 Million - $8.09 Million	50,814 New	50,814 $8.09 Million
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $6.12 Million - $7.4 Million	-65,775 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$95.88 - $117.08 $81,977 - $100,103	855 Added 1.32%	65,775 $7.37 Million
Q3 2021 Oct 26, 2021	BUY	$84.42 - $106.62 $50,989 - $64,398	604 Added 0.94%	64,920 $6.23 Million
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $115,360 - $144,515	1,705 Added 2.72%	64,316 $5.39 Million
Q1 2021 Apr 27, 2021	BUY	$67.06 - $75.82 $717,877 - $811,653	10,705 Added 20.62%	62,611 $4.22 Million
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $203,297 - $234,831	3,182 Added 6.53%	51,906 $3.63 Million
Q3 2020 Oct 26, 2020	BUY	$63.69 - $70.22 $19,807 - $21,838	311 Added 0.64%	48,724 $3.38 Million
Q2 2020 Jul 27, 2020	SELL	$58.54 - $67.94 $81,312 - $94,368	-1,389 Reduced 2.79%	48,413 $3.17 Million
Q1 2020 Apr 27, 2020	SELL	$49.46 - $64.78 $113,807 - $149,058	-2,301 Reduced 4.42%	49,802 $3 Million
Q4 2019 Jan 27, 2020	SELL	$49.86 - $58.26 $39,389 - $46,025	-790 Reduced 1.49%	52,103 $3.02 Million
Q3 2019 Oct 25, 2019	BUY	$47.54 - $53.43 $283,053 - $318,122	5,954 Added 12.68%	52,893 $2.74 Million
Q2 2019 Jul 30, 2019	BUY	$46.79 - $52.47 $2.2 Million - $2.46 Million	46,939 New	46,939 $2.4 Million

Others Institutions Holding NVO

# of Institutions

1,805

Shares Held

325M

Call Options Held

11.4M

Put Options Held

10.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $153B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Novo Nordisk A S Transaction History